A recent study shows more about the genes behind attention-deficit/hyperactivity disorder (ADHD) and could help scientists develop new treatment drugs with fewer side effects.
The research suggests the importance of glutamate receptor metabotropic (GRM) network genes and mutations there in predicting ADHD.
Dr. Seth Sullivan from Baylor Scott & White Health helped break down the findings and what they mean to the millions of families affected by ADHD.
For Dr. Sullivan's full comments, see the video above. For more information on the research, visit the Related Links.